News

Medical Polymers Pave the Way for More Efficient Medical Device Tech

A state panel has awarded nearly $300,000 to a nonprofit group that will coordinate efforts to enhance the technology ecosystem in the Roanoke, New River Valley and Lynchburg regions.

The grant from the GO Virginia state board comes with $150,000 in matching funds from local supporters.

The board also approved $100,000 for a study of the best future use of the Central Virginia Training Center, a state institution in Madison Heights that is scheduled to close next year, according to a news release from GO Virginia’s Region 2, which represents the Roanoke, New River, Lynchburg and Alleghany Highland areas.

GO Virginia is a statewide initiative designed to encourage Virginia’s economic growth through the creation of high-wage jobs. Nine regional councils vet applications and recommend projects in their respective areas.

In October, the Region 2 council backed $299,995 in state funding for the Valleys Innovation Council, a Blacksburg-based nonprofit formed last year, to create a Regional Entrepreneurship Initiative to facilitate coalitions and stakeholder engagement.

The initiative will convene a steering group to oversee efforts in three sub-regions: the New River Valley, the Roanoke Valley-Alleghany Highlands, and the Lynchburg area.

A pipeline of projects will be developed, with one measurement of progress being the number of grants from GO Virginia and other sources to support business startups and other innovation and entrepreneurship efforts in the region’s industry clusters.

Fields include advanced manufacturing, life science and health care, and emerging technologies such as autonomous systems, blockchain and cybersecurity.

While the area tops state and national averages for academic research expenditures, that has failed to translate into economic growth at the rate desired by organizers. Region 2 has a 5% rate of new business formation, compared to 7% for Virginia and 8% for the United States.

Aiming to reverse that trend, the Valleys Innovation Council has outlined a number of steps to be implemented on a quarterly basis through the end of 2021.

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and